(Q40544021)

English

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study (English)

1 reference

Europe PubMed Central

21 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Khinchi MS

1

1 reference

Europe PubMed Central

21 September 2017

Poulsen LK

2

1 reference

Europe PubMed Central

21 September 2017

Carat F

3

1 reference

Europe PubMed Central

21 September 2017

André C

4

1 reference

Europe PubMed Central

21 September 2017

Hansen AB

5

1 reference

Europe PubMed Central

21 September 2017

Malling HJ

6

1 reference

Europe PubMed Central

21 September 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

59

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

45-53

1 reference

Europe PubMed Central

21 September 2017

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Minimization: A new method of assigning patients to treatment and control groups

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Sublingual immunotherapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1398-9995.2003.00387.X

21 January 2018

Identifiers

10.1046/J.1398-9995.2003.00387.X

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40544021&oldid=2093307671"